AAFA's Positions and Statements on Public Policies
AAFA develops policy statements, comments, and letters of support regarding public policies that affect those with asthma and allergies. AAFA and other health-focused groups write these. We want our positions and statements to teach community and government leaders about related issues. We also support or oppose policies that affect those living with asthma and allergies.
Read our latest statements, comments, and letters of support:
The Health Harms of Biomass – September 14, 2016
AAFA signed a letter urging Congress to oppose policies which would increase the use of biomass in the production of electricity.
AAFA Joins PIPC in Response to ICER – September 14, 2016
AAFA signed a letter from the Partnership to Improved Patient Care in response to the call for input from ICER.
AAFA Encourages ICER to Incorporate the Patient Perspective – September 13, 2016
The Institute for Clinical and Economic Review (ICER) is an independent non-profit organization that evaluates medical evidence and helps stakeholders interpret and apply evidence to improve patient outcomes and control costs. AAFA submitted comments emphasizing the need to include patients' perspectives in response to an ICER call for comments on how to improve their value framework development process.
AAFA Letter About Rising Costs of Epinephrine Auto-Injectors – August 24, 2016
AAFA’s CEO addresses issues of access and affordability of life-saving epinephrine auto-injectors.
Proposed Revisions to the Regional Haze Rule – August 10, 2016
AAFA and other organizations signed a letter to the EPA in support of proposed revisions that will strengthen the Regional Haze Rule. We also urged the EPA to reconsider updates that would weaken reporting requirements and delay emission reductions.
Kentucky Medicaid Allergy Testing Coverage – July 21, 2016
AAFA commented on a proposed change in Kentucky that would eliminate Medicaid coverage for allergy testing.
Nitrogen Oxide Emissions – July 19, 2016
AAFA signed a letter urging the EPA to propose a new standard to cut emissions of nitrogen oxides from trucks.
Near-Road Monitoring – June 30, 2016
AAFA and other health organizations signed a letter to the EPA expressing concern about potential plans to reduce the near-road monitoring program, which monitors air pollution near roadways.
Medicare Part B Payments – June 28, 2016
AAFA and other patient organizations signed a letter to Congress listing patient concerns about proposed changes to Medicare Part B payments.
School-Based Medicaid Programs – June 27, 2016
We signed a letter to CMS urging improvements to school-based Medicaid programs and better school health initiatives.
Allergy Immunotherapy and Compounding – June 6, 2016
AAFA’s President and CEO spoke at an FDA meeting about regulations that might impact patient access to allergy shot treatments.
National Defense Authorization Act – June 1, 2016
AAFA signed a letter in opposition to certain sections of the National Defense Authorization Act, which would prohibit funding for most medical research at the Department of Defense (DoD). This limit on medical research could harm the health and well-being of military families.
Letter To NBC: Jokes About Food Allergies Can Put People in Danger – May 12, 2016
AAFA sent a letter to NBC expressing concern over a Today Show segment that belittled the severity of food allergies.
Air Travel and Disabilities – May 10, 2016
AAFA commented to the Department of Transportation explaining why asthma and allergies should be taken into consideration as disabilities during airline travel.
Medicare Part B Payment Program – May 9, 2016
AAFA submitted separate comments to CMS about the proposal to change Medicare Part B payment in a way that could negatively impact patients with chronic or complex conditions.
Medicare Part B Payment Program – May 9, 2016
We signed a letter in opposition to a CMS proposal that would change Medicare Part B payment in a way that could negatively impact patients with chronic or complex condition
Allergy Protocols in Federal Facilities – April 22, 2016
AAFA sent a letter to Federal Occupational Health (FOH) in support of epinephrine stocking and improved allergy policies in federal facilities.
Children’s Health Programs – April 20, 2016
We signed a letter from the Coalition for Healthier Schools in support of funding for children’s health programs at the U.S. EPA.
National Center for Environmental Health Funding – April 20, 2016
We signed a letter in support of funding for the CDC’s National Center for Environmental Health.
National Asthma Control Program – April 4, 2016
AAFA signed a letter in support of funding for the CDC’s National Asthma Control Program.
Defense of Health Research (Senate) – April 4, 2016
Defense of Health Research (House) – April 4, 2016
AAFA signed a letter to Congress in support of funding for health research programs.
Climate Change and Health – April 4, 2016
In recognition of National Public Health Week, AAFA and other health organizations signed an official Declaration on Climate Change and Health.
Medicare Advantage Cuts – March 31, 2016
AAFA and other health organization sent a letter to the Centers for Medicare and Medicaid Services to express concern about cuts to Medicare Advantage.
Medicare Payments – March 25, 2016
We joined with other health and medical organizations to sign a letter regarding Medicare Part D recommendations.
Agency for Healthcare Quality and Research Funding (House) – March 14, 2016
We signed a letter to Congress in support of funding for the Agency for Healthcare Quality and Research (AHRQ).
School-Based Asthma Management Programs Act – March 7, 2016
AAFA sent a letter of support to the sponsors of the School-Based Asthma Management Programs Act (HR 4662).
AAFA Comments on Allergen Immunotherapy at American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting – March 7, 2016
AAFA’s President and CEO, Dr. Cary Sennett, spoke at the AAAAI meeting about the importance of allergen shot treatments. Proposed changes to USP 797 pose a threat to patients by disrupting access to allergy immunotherapy.
Diversity in Clinical Trials – February 29, 2016
AAFA’s Senior Vice President of Policy, Advocacy, and Research, Meryl Bloomrosen, spoke at an FDA meeting about the importance of diversity in clinical trials and involving patients in research.
South Carolina’s Emergency Anaphylaxis Treatment Act – February 23, 2016
AAFA sent a letter in support of South Carolina’s Emergency Anaphylaxis Treatment Act, which would expand access to epinephrine in public places.
Clean Power Plan – February 12, 2016
Along with other health organizations, we signed a letter to the National Governors Association urging state governors to move forward with the EPA’s Clean Power Plan.
School Asthma Policies – February 1, 2016
We sent a letter to the Congressional Allergy and Asthma Caucus expressing concern about recent asthma emergencies in Texas schools.
Allergen Immunotherapy – January 29, 2016
We submitted comments regarding proposed regulations that could threaten the availability of immunotherapy treatments (allergy shots) in the United States.
Amtrak Pet Policy – January 29, 2016
AAFA sent a letter to Amtrak leadership expressing concern about a pilot program that would allow pets to travel on trains.
Amtrak Response to AAFA – February 9, 2016
Read Amtrak's response to AAFA's letter.
Food Labeling Modernization Act – January 27, 2016
AAFA sent a letter to the sponsors of the Food Labeling Modernization Act of 2015 to thank them for introducing the legislation.
FDA Allergenic Products Advisory Committee Spoken Comments – January 21, 2016
AAFA CEO Cary Sennett represented allergy patients’ perspective in testimony before the FDA’s Allergenic Products Advisory Committee.
FDA Allergenic Products Committee Presentation
Smoke-free Housing – January 19, 2016
AAFA submitted comments to the Department of Housing and Urban Development (HUD) in support of HUD’s proposed ban on smoking in public housing units.
Every Student Succeeds Act – January 21, 2016
As part of the Working to Improve Student Health (WISH) coalition, AAFA signed a letter in support of the Every Student Succeeds Act (ESSA).
Nucala™ (Mepolizumab)Comments – January 12, 2016
We submitted comments to the Institute for Clinical and Economic Review (ICER) regarding Nucala (Mepolizumab) treatment for asthma.
Nucala™ Mepolizumab Cover Letter
Protection of Research Participants – January 6, 2016
AAFA sent comments to the Department of Health and Human Services about how to update and improve protections for patients participating in clinical research.
Health Homes Program – December 21, 2015
We signed a letter in support of including asthma as one of the chronic conditions addressed by California’s Department of Health Care Services’ Health Homes Program.
Assistant Secretary for Health at HHS – November 24, 2015
AAFA and other organizations signed a letter in support of Dr. Karen DeSalvo’s nomination for Assistant Secretary for Health at the Department of Health and Human Services.
FDA Patient Engagement Advisory Committee – November 20, 2015
AAFA submitted comments to the FDA expressing disappointment that the FDA was not planning to include a greater number of patient representatives on the Patient Engagement Advisory Committee.
EPA Carbon Limit Protection (Senate) – November 16, 2015
EPA Carbon Limit Protections (House of Representatives) – November 16, 2015
AAFA joined other health organizations in signing a letter to the Senate and the House of Representatives opposing two Congressional Review Acts (CRA) that would block the EPA’s Clean Power Plan and carbon limits for new power plants.
CDC Funding – November 16, 2015
AAFA signed a letter to Congress to support strong funding for the CDC in any Fiscal Year 2016 spending legislation.
AHRQ Funding (Senate) – October 22, 2015
AHRQ Funding (House of Representatives) – October 22, 2015
AAFA signed a letter to Congress to support funding for the Agency for Healthcare Research and Quality (AHRQ).
Medication Therapy Management (MTM) – October 16, 2015
AAFA signed a letter to Senators Isakson and Warner, co-chairs of the Senate Finance Committee Chronic Care Working Group, to support the Medication Therapy Management Empowerment Act of 2015 in their legislative efforts.
National Asthma Control Program – September 11, 2015
AAFA and other organizations supported funding for the CDC’s National Asthma Control Program in Fiscal Year 2016.
Institute of Medicine Food Allergy Study – August 30-September 1, 2015
AAFA commented to the Institute of Medicine regarding the study Food Allergies: Global Burden, Causes, Treatment, Prevention, and Public Policy.
Ozone Pollution Limit – August 11, 2015
We signed a letter to President Obama to show support of better ozone limits in the air.
The Elementary and Secondary Education Act – August 7, 2015
We signed a letter to Congress to support an asthma management provision in the Elementary and Secondary Education Act (ESEA).
Medication Therapy Management – August 6, 2015
We signed a letter asking the Centers for Medicare and Medicaid Services (CMS) to allow more at-risk elderly patients to participate in the Medicare Part D Medication Therapy Management (MTM) program.
Clean Air Protections – August 4, 2015
We joined other health and medical groups to stand against a bill that would affect how clean the air is. This includes the Clean Air Act and the Clean Power Plan.
The Clean Power Plan – August 3, 2015
We praised the President’s message of the EPA’s Clean Power Plan Final Rule.
A Declaration on Climate Change and Health – June 23, 2015
We joined other groups to restate the public health community’s promise to look at climate change as a health issue.
Secondary Preventive Services – June 19, 2015
We signed a letter of support to the Treasury Secretary Jack Lew about secondary preventive services. These keep a disease or illness from getting worse. They also help those with asthma manage it and prevent related problems.
Electronic Health Records – June 15, 2015
We sent comments to the CMS about possible changes to the Electronic Health Record Incentive Program.
Improving Care for Medicare-Aged Population – June 14, 2015
We sent comments to the Senate Chronic Care Working Group. We offered options for better care for Medicare patients.
Part D Beneficiary Appeals Fairness Act – June 1, 2015
AAFA signed a letter in support of the Part D Beneficiary Appeals Fairness Act. This enables seniors to appeal if their medication is put on a Medicare Part D Specialty Tier.
National Heart, Lung, and Blood Institute Strategic Vision – May 15, 2015
We sent comments to the National Heart, Lung, and Blood Institute (NHLBI) about research for the next 10 years.
The Family Asthma Act of 2015 – May 15, 2015
We support the Family Asthma Act of 2015. This act would make asthma research and public education better in the United States.
The School Asthma Management Plans Act – May 15, 2015
We support the School Asthma Management Plans Act. This would allow schools to improve how they manage asthma care.
NIH Innovation Fund – May 13, 2015
AAFA signed a letter to support funds for the National Institutes of Health (NIH) included in the 21st Century Cures Act draft bill.
The Climate Change Health Promotion and Protection Act – April 13, 2015
We signed a letter to Representative Lois Capps. We thanked her for bringing back the Climate Change Health Promotion and Protection Act. This act would help address the threat of climate change on health.
Ratepayer Protection Act – April 13, 2015
AAFA and other health groups signed a letter against to the Ratepayer Protection Act. This act would delay and block critical clean air protections.
Medication Costs and the Impact on Patients – April 9, 2015
AAFA’s President and CEO, Dr. Cary Sennett, spoke at a congressional briefing about the impact rising medication costs will have on patients
Children’s Health Programs Funding – March 26, 2015
We signed a letter to support more money for federal programs that help schools reduce indoor air pollution. This would occur through the Environmental Protection Agency’s (EPA)’s office of Children’s Health Protection and the Office of Radiation and Indoor Air.
Agency for Healthcare Research and Quality Funding – March 20, 2015
We signed a letter against ending the Agency for Healthcare Research and Quality (AHRQ) in the House Labor HHS Subcommittee’s 2016 spending bill.
Ozone Standards – March 17, 2015
AAFA and other health groups sent comments to the U.S. Environmental Protection Agency (EPA) on the proposed National Ambient Air Quality Standards. This would limit the amount of harmful ozone in the air.
Dormant Therapies and 21st Century Cures – March 17, 2015
AAFA and other health groups signed a letter that the Dormant Therapies Act be included in the 21st Century Cures Act draft bill. This would help develop new cures for diseases. It would improve the quality of life for Americans with chronic diseases.
National Asthma Control Program – March 11, 2015
AAFA and other asthma organizations signed a letter to support more money for the National Asthma Control Program at the Centers for Disease Control and Prevention (CDC).